- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04355312
Using INDOcyanine Green to Analyse Ovarian Vascularization After Ovarian Laparoscopic CYStectomy (KYSINDO)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The study will be open to any patient meeting the inclusion / exclusion criteria, scheduled for intraperitoneal cystectomy or cyst destruction using Plasmajet, corresponding to a benign organic cyst requiring surgical treatment according to current recommendations.
It will proceed as follows:
- Recruitment of patients during the preoperative consultation. The information form will be given to the patient.
- The day before the intervention: Inclusion proposed to the patient after re-explanation of the objectives and the progress of the study, submission of the consent form for the patient to sign. Realization of an ultrasound with count of antral follicles, and description of the ovarian cyst (size, aspect, IOTA criteria). Performing a blood test with AMH measurement to assess the preoperative ovarian reserve.
- The day of the intervention: Intraoperative, injection at the end of the procedure of a bolus of indocyanine green intravenously. Studied through an infrared camera system - the SPIES system (KARL STORZ GmbH & Co. KG, Tuttlingen, Germany) - fluorescence within the ovary will bring out the vascularization of the area of cystectomy or destruction of the cyst. Evaluation of the degree of fluorescence (between 0 and 4, on the model of a Likert scale) carried out at the area of cystectomy or destruction of the cyst. Then, the second evaluation technique using the METAMORPH software will assign a raw and objective score according to the fluorescence visualized. The 2 evaluation results will be compared with each other.
- Postoperatively: there will be no special clinical or biological monitoring. If undesirable effects related to Indocyanine Green occur, they will be noted.
- After discharge, as part of her standard follow-up for short-term desire for pregnancy: she will have a postoperative consultation planned 1 month after the intervention, followed by examination at 6 months and 12 months with an ultrasound for evaluation CFA and blood work with AMH.
Any natural pregnancy will be noted.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Clermont-Ferrand, France, 63000
- CHU de Clermont-Ferrand
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- An adult woman of childbearing potential who has a desire for short-term pregnancy, under the age of 42, to undergo laparoscopic accessible surgical treatment (<10 cm) for a benign organic ovarian cyst (serous, mucinous, dermoid or endometriotic) whose diagnosis was made on imaging (ultrasound or MRI).
- Patient able to provide informed consent to her participation in the study.
- Patient covered by the " Sécurité Social " insurance system.
Exclusion Criteria:
- Adult patient under protection, tutorship or curatorship.
- Refusal of the patient or poor understanding of the French language.
- Known allergy to iodine.
- Current pregnancy or breastfeeding
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Kysindo
Group of 45 patients with short-term desire for pregnancy who will undergo laparoscopic ovarian cystectomy with use of indocyanine green.
Evaluation of the ovarian reserve preoperatively and longitudinal cohort follow-up after surgery at 6 months and 12 months.
Analysis by a new imaging technique.
|
During intraperitoneal cystectomy or Plasmajet destruction of the cyst, as a benign organic cyst requiring surgical treatment, peroperatively, at the end of the cystectomy procedure, injection by the anesthetist on a peripheral venous route of a bolus of Indocyanine green diluted 0.2mg / kg. Installation of the SPIES camera system (KARL STORZ GmbH & Co.KG, Tuttlingen, Germany). Evaluation of the degree of fluorescence at the location of cystectomy or destruction of the cyst. A fluorescence score between 0 and 4 (on the model of a Likert scale) will be used for the evaluation of fluorescence. A second reading of the Likert scale results will be carried out by a second inspector so that the score is as objective as possible. Then, second evaluation technique realized by the METAMORPH software, which will assign a raw and objective score according to the fluorescence visualized. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Fluorescence uptake or not at the area of cystectomy (binary criterion)
Time Frame: Inoperative
|
A fluorescence score based on a Likert scale will be used.
The presence of fluorescence will correspond to a success, defined by a value on the scale strictly greater than 0. The absence of fluorescence will be a failure, defined as equal to 0. The judgment criterion will therefore be binary (fluorescence uptake or no at the area of cystectomy), allowing the feasibility judgement.
|
Inoperative
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
METAMORPH Score
Time Frame: In immediate postoperative
|
Automatic and objective allocation by the METAMORPH software of a raw score according to the fluorescence visualized.
|
In immediate postoperative
|
Rate of Side Effects
Time Frame: In per and immediate postoperative
|
Accounting for side effects and the occurrence of post-operative complications related to the injection of Indocyanine green.
|
In per and immediate postoperative
|
Added time
Time Frame: Immediate post operativ
|
Estimation of the protocol-related time added to the total operating time.
|
Immediate post operativ
|
AMH dosage
Time Frame: Preoperatively
|
Evaluation of the ovarian reserve biological by AMH dosage in comparison of the fluorescence scores.
Study of natural fertility in the year following the cystectomy in the patients wishing for pregnancy.
|
Preoperatively
|
AMH dosage
Time Frame: Month 6
|
Evaluation of the ovarian reserve biological by AMH dosage in comparison of the fluorescence scores.
Study of natural fertility in the year following the cystectomy in the patients wishing for pregnancy.
|
Month 6
|
AMH dosage
Time Frame: Month 12
|
Evaluation of the ovarian reserve biological by AMH dosage in comparison of the fluorescence scores.
Study of natural fertility in the year following the cystectomy in the patients wishing for pregnancy.
|
Month 12
|
Evaluation of the ovarian reserve by ultrasound by CFA
Time Frame: Preoperatively
|
Evaluation of the ovarian reserve biological by by ultrasound by CFA in comparison of the fluorescence scores.
Study of natural fertility in the year following the cystectomy in the patients wishing for pregnancy.
|
Preoperatively
|
Evaluation of the ovarian reserve by ultrasound by CFA
Time Frame: Month 6
|
Evaluation of the ovarian reserve biological by by ultrasound by CFA in comparison of the fluorescence scores.
Study of natural fertility in the year following the cystectomy in the patients wishing for pregnancy.
|
Month 6
|
Evaluation of the ovarian reserve by ultrasound by CFA
Time Frame: Month 12
|
Evaluation of the ovarian reserve biological by by ultrasound by CFA in comparison of the fluorescence scores.
Study of natural fertility in the year following the cystectomy in the patients wishing for pregnancy.
|
Month 12
|
Number of Participants with Pregnancy
Time Frame: Month 6
|
Study of natural fertility in the year following the cystectomy in the patients wishing for pregnancy.
|
Month 6
|
Number of Participants with Pregnancy
Time Frame: Month 12
|
Study of natural fertility in the year following the cystectomy in the patients wishing for pregnancy.
|
Month 12
|
Collaborators and Investigators
Investigators
- Principal Investigator: Anne-Sophie GREMEAU, University Hospital, Clermont-Ferrand
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- AOI 2019 GREMEAU
- 2019-001966-14 (Other Identifier: 2019-001966-14)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ovarian Cysts
-
Ann & Robert H Lurie Children's Hospital of ChicagoUnknownCystectomy | Benign Cysts Ovarian | Torsion | Malignant Cysts OvarianUnited States
-
Sorlandet Hospital HFUniversity of SurreyCompleted
-
Shandong Provincial HospitalShandong UniversityCompleted
-
Ain Shams UniversityNot yet recruitingOvarian Cyst Benign
-
Seoul National University HospitalCompletedOvarian Cyst BenignKorea, Republic of
-
Peking University Third HospitalRecruitingPolycystic Ovary SyndromeChina
-
University Hospital, MontpellierBaxter Healthcare CorporationNot yet recruitingBenign Ovarian Cyst | CystectomyFrance
-
Ahmed MagedCompletedPolycystic Ovarian Syndrome
-
University of AarhusCompletedPolycystic Ovarian DiseaseDenmark
-
Assiut UniversityNot yet recruiting
Clinical Trials on Use of Indocyanine Green in laparoscopic ovarian cystectomy
-
Fujian Medical UniversityNot yet recruitingGastric Cancer | Surgery
-
Jilin UniversityUnknownColorectal Cancer | Indocyanine GreenChina
-
Jilin UniversityUnknownEndoscopic Submucosal Injection of Indocyanine GreenChina
-
Cantonal Hosptal, BasellandUnknownIndication for Laparoscopic Surgery (Any)Switzerland
-
The Hospital for Sick ChildrenCanadian Institutes of Health Research (CIHR)Completed
-
The Hospital for Sick ChildrenCanadian Institutes of Health Research (CIHR)Completed
-
Hacettepe UniversityStanford University; St. Marianna University School of MedicineCompletedActivation of Primordial FolliclesTurkey
-
University Hospital, GhentJohnson & JohnsonCompleted
-
South Valley UniversityRecruitingPregnancy OutcomeEgypt
-
N.N. Petrov National Medical Research Center of...RecruitingTesticular Germ Cell TumorRussian Federation